Drug Database
Back to search

United States· US:43598-305_35e92030-ae2f-04b2-c3de-69f8c8da6b82

Azacitidine

A azacitidine product containing azacitidine, registered in United States by Dr. Reddy's Laboratories Inc.. The same ATC class is registered in 18 of our 19 countries.

ATC L01BC07US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAzacitidineATCL01BC07REGISTER NO.US:43598-305_35e92030…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about azacitidineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Azacitidine is registered in 18 of 19 countries.

Countries holding a registration under ATC L01BC07 (azacitidine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search azacitidine products by name

Azacitidine · ATC L01BC07

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of azacitidine costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.69 in France to $470.17 in Switzerland — a ×683 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Azacitidine · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$470.17
  • CZ Czechia$4.72
  • FR France$0.69
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
AZACITIDINE
Manufacturer
Dr. Reddy's Laboratories Inc.
Country
United States (US)
ATC code
L01BC07
ATC class
Azacitidine
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    4359830562
    1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (43598-305-62)
  • ndc11
    43598-305-62

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

75 interactions on record for azacitidine.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check azacitidine against other medicinesHow interaction checks work

Azacitidine · interactions on record

75 records

  • 30 severe
  • 45 moderate

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Azacitidine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All azacitidine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Azacitidin Hikma, Azacitidin Sandoz
  • Belgium · Azacitidin Sandoz, Azacitidine Eugia
  • Bulgaria · Азацитидин, Азацитидин Ромфарм
  • Cyprus · Azacitidine Koanaa 25 Mg/Ml, Azacitidine Sandoz
  • Czechia · Azacitidin Sandoz, Azacitidine Rompharm
  • Germany · Azacitidin, Azacitidin Aqvida
  • Denmark · Azacitidin "stada Arzneimittel Ag", Azacitidin Adalvo
  • Estonia · Azacitidine Auxilia
  • Spain · Azacitidina Dr. Reddys, Azacitidina Eugia
  • Finland · Azacitidine Hikma, Azacitidine Sandoz
  • France · Azacitidine Arrow, Azacitidine Biogaran
  • United Kingdom (Northern Ireland) · Azacitidine Amarox, Azacitidine Eugia (Uk)
  • Greece · Azacitidine Sandoz, Azacitidine Stada
  • Croatia · Azacitidin Pharmascience, Azacitidin Sandoz
  • Hungary · Azacitidin Aliud, Azacitidin Sandoz
  • Ireland · Azacitdine Clonmel, Azacitidine Clonmel
  • Iceland · Azacitidine Accord, Azacitidine Glenmark
  • Italy · Azacitidina Aurobindo, Azacitidina Eg Stada
  • Liechtenstein · Azacitidine Accord, Azacitidine Kabi
  • Lithuania · Azacitidine Auxilia, Azacitidine Icg Farma
  • Luxembourg · Azacitidine Azacitidine Eg 25 Mg/Ml Poudre Pour Suspension Injectable, Azacitidine Eurogenerics
  • Malta · Azacitidine Adalvo, Azacitidine Lotus
  • Netherlands · Azacitidine, Azacitidine Cf
  • Norway · Azacitidin Sun, Azacitidin Tillomed
  • Poland · Azacitidine Eugia, Azacitidine Msn
  • Portugal · Azacitidina Eugia, Azacitidina Hikma
  • Romania · Azacitidină Aqvida, Azacitidină Dr. Reddy’s
  • Sweden · Azacitidine Azacitidine Lotus Pharma, Azacitidine Hikma
  • Slovenia · Azacitidin Sandoz, Azacitidin Stada
  • Slovakia · Azacitidine Glenmark, Azacitidine Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/53e2ecd5-8635-4029-a5d2-274509ecad87
GET /v1/drugs/53e2ecd5-8635-4029-a5d2-274509ecad87?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS; SUBCUTANEOUS",
  "source": "ndc",
  "strength": "100",
  "substance": "AZACITIDINE",
  "productndc": "43598-305",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA201537",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about azacitidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console